www.bna.com Pharmaceutical Law & Industry Report
HomeIndexTable of CasesFeedbackwww.bna.com

Printable version (PDF) 

TABLE OF CASES
Vol. 8, Nos. 1-50, pp. 1-1650
Jan. 1 -- Dec. 31, 2010

# | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

    Cacchillo v. Insmed Inc. (N.D.N.Y.), 1399
    Cadila Healthcare Ltd.; Shire Dev. Inc. v. (D. Del.), 947
    Cain v. Merck & Co. (N.J. Super. Ct. App. Div.), 1147
    Caldwell ex rel. Louisiana v. Janssen Pharmaceutica Inc. (La. Parish Ct.), 1342
    California Pharmacists Ass'n v. Maxwell-Jolly (9th Cir.), 319
    Campbell v. Matrixx Initiatives Inc. (D. Idaho), 239
    Cancer Research Tech. Ltd. v. Barr Labs. Inc. (D. Del.), 385; (Fed. Cir.), 385; 1457
    Cancer Research Tech. Ltd. v. Teva Pharms. USA Inc. (D. Del.), 119
    Caraco Pharm. Labs. Ltd.; Novo Nordisk A/S v. (Fed. Cir.), 512; 1016; (E.D. Mich.), 1303
    CareToLive v. FDA (6th Cir.), 203
    Carpenter, U.S. ex rel. v. Abbott Labs. (D. Mass.), 943
    Celgene Corp.; Attorney Gen. of Canada v. (Canada, Fed. Ct. App.), 533; (Canada), 570
    Celgene Corp. v. Teva Pharms. USA Inc. (D.N.J.), 156
    Centocor Inc. v. Abbott Labs. (E.D. Tex.), 6
    Centocor Inc. v. Hamilton (Tex. Ct. App.), 317
    Centocor Ortho Biotech Inc.; DeGidio v. (N.D. Ohio), 1469
    Cephalon Inc. v. Apotex Corp. (D. Del.), 1107
    Cephalon Inc.; Giant Eagle Inc. v. (N.D. Ohio), 748
    Cephalon Inc.; King Drug Co. of Florence Inc. v. (E.D. Pa.), 412
    Cephalon Inc. v. Watson Pharms. Inc. (D. Del.), 36
    Chanin v. Teva Parenteral Medicines Inc. (Nev. Dist. Ct.), 625
    Chartock, U.S. ex rel. v. Elan Corp. (D. Mass.), 1578
    Cipro Cases I and II, In re (Cal. Ct. App.), 681
    Ciprofloxacin Hydrochloride Antitrust Litig., In re (2d Cir.), 579
    City of
      See name of city
    Clark v. Pfizer Inc. (Pa. Super. Ct.), 129
    Classen Immunotherapies v. Biogen Idec Inc. (U.S., rem), 851
    Clayworth v. Pfizer Inc. (Cal.), 914; (Cal. Ct. App.), 1183
    Coalition for Common Sense in Gov't Procurement v. U.S. (D.D.C.), 210
    Cobalt Pharms. Inc.; Hoffmann-LaRoche Inc. v. (D.N.J.), 1087; 1182; 1460
    Cochran v. Wyeth Inc. (Pa. Super. Ct.), 1022
    Cody Labs. Inc. v. Sebelius (D. Wyo.), 980; 1500
    Colacicco v. Apotex Inc. (E.D. Pa.), 11
    Coleman v. Wyeth Pharms. Inc. (Pa. Super. Ct.), 1220
    Conrad, U.S. ex rel. v. Eon Labs Inc. (D. Mass.), 232
    Conrad, U.S. ex rel. v. Grifols Biologicals Inc. (D. Md.), 918; 1143
    Conrad, U.S. ex rel. v. Schwarz Pharma (D. Mass.), 585
    Conrad, U.S. ex rel. v. Schwarz Pharma (S.D. Tex.), 585
    Cooper v. Matrixx Initiatives Inc. (D. Idaho), 239
    Cooper v. Wyeth Inc. (M.D. La.), 1401
    Copeland, U.S. ex rel. v. Novartis Pharms. Corp. (E.D. Pa.), 1269
    CorePharma LLC; King Pharms. Inc. v. (D.N.J.), 641
    County of
      See name of county
    Cruz v. Mylan Inc. (M.D. Fla.), 279
    CVS Caremark Corp.; Muecke Co. v. (S.D. Tex.), 1307
    CVS Pharmacy Inc., In re (Mass. Super. Ct.), 1156

Contact the Webmaster at webmaster@bna.com
1801 S. Bell Street, Arlington, VA 22202 - Phone: 1-800-372-1033

Copyright © The Bureau of National Affairs, Inc. All Rights Reserved.